Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2026)
Elanco Animal Health (ELAN) posted Non-Current Debt of $3.7 billion for Q1 2026, down 0.69% sequentially from $3.8 billion in Q4 2025, and down 14.13% YoY from $4.4 billion in Q1 2025.
Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2026) Analysis & Trends
Elanco Animal Health has reported Non-Current Debt for 9 years, with the latest figure at $3.7 billion in Q1 2026.
- Quarterly Non-Current Debt fell 14.13% year-over-year to $3.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 billion (down 14.13% YoY) and the FY2025 annual result came in at $3.8 billion, down 12.04% from the prior year.
- Non-Current Debt slipped to $3.7 billion in Q1 2026 per ELAN's latest filing, from $3.8 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $6.1 billion in Q1 2022 and troughed at $3.7 billion in Q1 2026.
- A 5-year average of $5.0 billion and a median of $5.4 billion in 2022 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2023 and 2024: Non-Current Debt grew 5.98% in 2023, then declined 28.72% in 2024.
- Over 5 years, Non-Current Debt stood at $5.4 billion in 2022, then grew by 5.98% to $5.8 billion in 2023, then decreased by 25.93% to $4.3 billion in 2024, then retreated by 12.04% to $3.8 billion in 2025, then dropped by 0.69% to $3.7 billion in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $3.7 billion, $3.8 billion, and $4.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 130.00 Mn |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 1.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.85 Bn |
| Mar 31, 2026 | 3.74 Bn |
| Dec 31, 2025 | 3.76 Bn |
| Sep 30, 2025 | 3.96 Bn |
| Jun 30, 2025 | 4.15 Bn |
| Mar 31, 2025 | 4.35 Bn |
| Dec 31, 2024 | 4.28 Bn |
| Sep 30, 2024 | 4.36 Bn |
| Jun 30, 2024 | 4.32 Bn |
| Mar 31, 2024 | 5.73 Bn |
| Dec 31, 2023 | 5.77 Bn |
| Sep 30, 2023 | 5.87 Bn |
| Jun 30, 2023 | 6.06 Bn |
| Mar 31, 2023 | 5.64 Bn |
| Dec 31, 2022 | 5.45 Bn |
| Sep 30, 2022 | 5.90 Bn |
| Jun 30, 2022 | 6.01 Bn |
| Mar 31, 2022 | 6.13 Bn |
| Dec 31, 2021 | 6.32 Bn |
| Sep 30, 2021 | 6.33 Bn |